TMDX ALERT: TransMedics Group, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Company Overview - TransMedics Group, Inc (Nasdaq: TMDX) is under investigation for potential securities law violations [8] - Shares of TransMedics Group dropped over 11% on January 10 following an investigative report by Scorpion Capital [1] Allegations and Investigations - Scorpion Capital's report alleges fraudulent billing schemes, off-label misuse of devices, and reliance on kickbacks to drive sales [1] - The report highlights ongoing regulatory scrutiny, including investigations by the DOJ, IRS, and state attorneys general into Medicare fraud linked to organ acquisition costs [1] - Prominent transplant centers have discontinued use of TransMedics devices, citing concerns over clinical value [1] Legal Actions - Block & Leviton is investigating potential securities law violations by TransMedics Group [3] - The law firm may file an action to recover losses on behalf of investors who have lost money [3] - Block & Leviton has a track record of recovering billions of dollars for defrauded investors [6] Investor Impact - Investors who purchased TransMedics Group common stock and experienced losses may be eligible for recovery, regardless of whether they have sold their investment [2] - Investors are encouraged to contact Block & Leviton to learn more about potential recovery options [4][8] Whistleblower Information - Individuals with non-public information about TransMedics Group may assist in the investigation or file a report with the SEC under the whistleblower program [5] - Whistleblowers providing original information to the SEC may receive rewards of up to 30% of any successful recovery [5]